Table 3.

Outcomes before and after propensity score matching with Cohort 1 buprenorphine-naloxone and Cohort 2 opioid use disorder controls.

	Cohort 1	Cohort 2	RR (95% CI)	P-value
Mortality before PSM	1,628 (2.64%)	6,352 (3.99%)	0.66 (0.63–0.70)	P < 0.001
Mortality after PSM	1,628 (2.64%)	1,878 (3.04%)	0.87 (0.81–0.93)	P < 0.001
Remission before PSM	6,984 (18.78%)	11,163 (10.08%)	1.86 (1.81–1.91)	P < 0.001
Remission after PSM	6,984 (18.78%)	4,589 (10.36%)	1.81 (1.75–1.88)	P < 0.001

OUD, opioid use disorder; PSM, propensity score matching; RR, relative risk; CI, confidence interval.